MediPharm Labs (TSE:LABS) has released an update.
MediPharm Labs Corp. reports the successful election of director nominees and the reappointment of MNP LLP as auditor at its 2024 Annual Meeting of Shareholders. With a strong turnout, shareholders represented 14.72% of outstanding shares and overwhelmingly supported the proposed resolutions. The company, known for its pharmaceutical-grade cannabis products and recent expansion through the acquisition of VIVO Cannabis Inc., continues to adhere to high standards of manufacturing and compliance in the global medical cannabis market.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.
